Company Filing History:
Years Active: 2018-2024
Title: Innovations by Robert Henk Henning
Introduction
Robert Henk Henning is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for vasoconstriction-related diseases. With a total of six patents to his name, Henning's work is recognized for its potential impact on healthcare.
Latest Patents
Henning's latest patents focus on medicaments for the treatment of vasoconstriction-related disorders. One of his inventions relates to the (2R) enantiomeric form of a 6-chromanol derivative, which is designed for use in the prophylaxis or treatment of such conditions. This includes various derivatives such as (6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(piperazin-1-yl)methanone and N-(benzyl)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide. Additionally, he has developed the (S) enantiomeric form of certain 6-chromanol derivatives for use as a medicament, which also includes similar compounds and their pharmaceutically acceptable salts.
Career Highlights
Henning is currently associated with Sulfateq B.V., where he continues to innovate in the pharmaceutical sector. His work is characterized by a strong focus on developing effective treatments that address critical health issues.
Collaborations
Henning has collaborated with notable colleagues such as Adrianus Cornelis Van Der Graaf and Gerrit Jan Willem Euverink. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Robert Henk Henning is a distinguished inventor whose work in medicinal chemistry has the potential to significantly improve treatments for vasoconstriction-related disorders. His innovative contributions and collaborations highlight his commitment to advancing healthcare solutions.